Search results
Results from the WOW.Com Content Network
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.
Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto drug generated ...
Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]
The following is a list of the 21 largest civil settlements, reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2017, ordered by the size of the total civil settlement. Some of these matters also resolved criminal fines and penalties, listed in parentheses, but these amounts are not considered when ...
The new settlement could bring to a close a chapter in a long legal saga over the toll of an opioid crisis that some experts assert began after OxyContin hit the market in 1996. Since then ...
The credo is mentioned seven times in the current chairman and chief executive’s latest annual letter to shareholders. As is tradition, it is reprinted in full at the beginning of the annual report. It is also carved in stone in the lobby of J&J headquarters and posted at all significant company events—including that morning’s stock ...
The following newspapers are published in Dallas, Texas, United States): Auto Revista; Daily Commercial Record; Dallas Business Journal; The Dallas Morning News. Al Día - produced by The Dallas Morning News; Quick - produced by The Dallas Morning News; Dallas Examiner; Dallas Observer; Dallas Voice; El Extra; Reform Dallas; Slavic Voice of America
Total settlement: $3.7 billion. Deadline to file: Undisclosed. Requirements: Must have been a Wells Fargo client with an active banking account, mortgage or auto loan between 2011 and 2022.